<DOC>
	<DOCNO>NCT01190072</DOCNO>
	<brief_summary>The purpose study follow management blood lipid patient plan percutaneous coronary intervention ( widen coronary vessel ) period 6 10 week intervention .</brief_summary>
	<brief_title>Lipid-lowering Therapy Secondary Prevention Patients Undergoing Elective Percutaneous Coronary Intervention ( PCI )</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Male nonpregnant female Coronary patient hospitalise elective PCI Hypercholesterolaemia define LDLC â‰¥ 2 mmol/L Any chronic inflammatory condition Chronic antiinflammatory pharmacotherapy ( except lowdose ASA )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Blood lipid</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>lipid lowering treatment</keyword>
</DOC>